CA991543A - Immunostimulant agent, compositions thereof and methods for their preparation - Google Patents

Immunostimulant agent, compositions thereof and methods for their preparation

Info

Publication number
CA991543A
CA991543A CA159,414A CA159414A CA991543A CA 991543 A CA991543 A CA 991543A CA 159414 A CA159414 A CA 159414A CA 991543 A CA991543 A CA 991543A
Authority
CA
Canada
Prior art keywords
compositions
preparation
methods
immunostimulant agent
immunostimulant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA159,414A
Other versions
CA159414S (en
Inventor
Robert Fauve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of CA991543A publication Critical patent/CA991543A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13Tumour cells, irrespective of tissue of origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/742Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588Adjuvants of undefined constitution
    • A61K2039/55594Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA159,414A 1971-12-24 1972-12-19 Immunostimulant agent, compositions thereof and methods for their preparation Expired CA991543A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7146520A FR2164510B1 (en) 1971-12-24 1971-12-24

Publications (1)

Publication Number Publication Date
CA991543A true CA991543A (en) 1976-06-22

Family

ID=9088030

Family Applications (1)

Application Number Title Priority Date Filing Date
CA159,414A Expired CA991543A (en) 1971-12-24 1972-12-19 Immunostimulant agent, compositions thereof and methods for their preparation

Country Status (15)

Country Link
JP (1) JPS4868729A (en)
AR (1) AR195897A1 (en)
BE (1) BE793260A (en)
CA (1) CA991543A (en)
CS (1) CS190380B2 (en)
DE (1) DE2262427C3 (en)
DK (1) DK137887B (en)
ES (1) ES410435A1 (en)
FR (1) FR2164510B1 (en)
GB (1) GB1419969A (en)
IL (1) IL41120A (en)
NL (1) NL7217588A (en)
PL (1) PL89687B1 (en)
SU (1) SU592333A3 (en)
ZA (1) ZA728959B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2287901A1 (en) * 1974-10-14 1976-05-14 Pasteur Institut IMMUNOSTIMULANT MEDICINAL PRODUCT CONTAINING OSE DERIVATIVE OR PHOSPHORYL POLYOSE
JPS5835121A (en) * 1981-08-20 1983-03-01 ビラス・ヴィー・リクハイト Antigen consisting of immunostimulant aid and use in immunological therapy
CA1225592A (en) * 1983-08-26 1987-08-18 Ribi Immunochem Research Inc. Refined detoxified endotoxin
IT1186793B (en) * 1985-11-26 1987-12-16 Sibar Srl FRACTION OBTAINED FROM LISTERIA MONOCYTOGENES WITH THERAPEUTIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
JPH02131433A (en) * 1988-11-11 1990-05-21 Nisshin Flour Milling Co Ltd Preventive and therapeutic agent for nonspecific infectious diseases
EP3150323B1 (en) 2015-09-30 2020-11-18 Kabushiki Kaisha Toshiba Laser processing apparatus, laser processing method and distance measurement method
CN111642460B (en) * 2020-06-23 2022-06-28 山西省中医药研究院(山西省中医院) Construction method of pineal body injury rat model

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU57091A1 (en) * 1968-10-15 1970-04-16

Also Published As

Publication number Publication date
FR2164510B1 (en) 1975-02-07
IL41120A0 (en) 1973-02-28
SU592333A3 (en) 1978-02-05
ZA728959B (en) 1973-09-26
DK137887C (en) 1978-10-16
CS190380B2 (en) 1979-05-31
AR195897A1 (en) 1973-11-15
FR2164510A1 (en) 1973-08-03
ES410435A1 (en) 1976-01-01
JPS4868729A (en) 1973-09-19
DK137887B (en) 1978-05-29
NL7217588A (en) 1973-06-26
DE2262427B2 (en) 1979-08-09
DE2262427A1 (en) 1973-07-12
DE2262427C3 (en) 1980-04-24
GB1419969A (en) 1975-12-31
PL89687B1 (en) 1976-12-31
IL41120A (en) 1975-12-31
BE793260A (en) 1973-06-22

Similar Documents

Publication Publication Date Title
CA991543A (en) Immunostimulant agent, compositions thereof and methods for their preparation
CA945179A (en) Catalyst compositions, their preparation and use
CA979596A (en) Fluorine-containing copolymer compositions and method for their preparation
AU491274B2 (en) 'immunostimulant agent, compositions thereof and methods for their preparation
AU5042872A (en) 'immunostimulant agent, compositions thereof and methods for their preparation
CA926396A (en) 2,6-methano-3-benzazocines and preparation thereof
AU466717B2 (en) Novel herbicides, compositions and methods
AU471732B2 (en) 1,4-methano and ethano-tetrahydro-naphthloxypropanols and process for their preparation
CA877319A (en) Anti-diabetically effective benzene-sulphonyl-semicarbazides, process for their preparation, and compositions thereof
CA875539A (en) N6-aralkyl-adenosine derivatives, preparation and compositions thereof
CA851190A (en) Sulphonyl-ureas and sulphonyl-semicarbazides, preparation thereof and pharmaceutical compositions
AU4474772A (en) 14, 15b-EPOXYCARBENOLIDE AND 14, 15b-EPOXYBUFADIENOLIDEGLYCOSIDES AND PROCESS FOR THEIR PREPARATION
CA992959A (en) O-triazenobenzamides, compositions, use and preparation thereof
CA972376A (en) Thiazolotriazolylphosphonothioates, preparation and uses thereof
CA862783A (en) Benzohydroxamates, preparation and uses thereof
CA876743A (en) Biguanide-naphthalene-1,5-disulphonates and blood sugar-depressing compositions thereof
AU459016B2 (en) Perfluoroalkylarylamines, their preparation and use
AU472222B2 (en) Cardenolide-and bufadienolide-3/2', 3'-didesoxygl cosides and process for their preparation
CA870627A (en) 1,3,4-thiazolidine-2-thiones and their preparation
CA873352A (en) 1,2,3,4-tetrahydro-isoquinolines and their preparation
CA995685A (en) 3-tert.butyl-6-methyl-5-nitrosalicylanilides, methods of preparation and anthelmintic compositions thereof
CA873345A (en) Derivatives of nebularin, method of preparation and compositions thereof
CA866849A (en) Benzohydroxamates or benzohydroximates, preparation and uses thereof
AU425496B2 (en) 17-oxo-^1,3,5[10]-estratrienes and their preparation
CA834242A (en) 3,4-dihydroxyphenylalkanol amines and their preparation